No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Celltrion Launches Trastuzumab and Infliximab Biosimilars in Vietnam
On 28 August 2025, Celltrion announced that it has launched two biosimilars in Vietnam:• Remsima® SC, biosimilar to Janssen’s Remicade® (infliximab); and Herzuma®, biosimilar to Roche/Genentech’s Herceptin® (trastuzumab).